The nurse has taught a patient about sucralfate (Carafate). Which statement indicates that the patient requires further teaching?

A. "You will need to take an anticonvulsant of some type for your lifetime."

This statement may be accurate for some individuals with chronic or recurrent seizure disorders, but it is a generalization. The duration of anticonvulsant therapy varies from person to person, and some individuals may eventually be able to discontinue medication under the guidance of their healthcare provider.

B. "This medication should be taken until you haven't had a seizure for a month."

While seizure control is a factor in determining the duration of treatment, setting a specific timeframe (e.g., one month) may not be applicable to everyone. The decision to continue or discontinue anticonvulsant therapy is usually individualized and based on various factors, including the type of seizure disorder and the individual's response to treatment.

C. "Seizures are unpredictable and so is the duration of the treatment."

This is the best response. It acknowledges the variability in seizure disorders and the individualized nature of treatment duration. Seizure management is often an ongoing process that requires monitoring and adjustments based on the person's specific circumstances.

D. "You will only need to take it for a short period of time because anticonvulsants will cure the seizure disorder."

Anticonvulsants are typically used to manage and control seizures rather than cure the underlying seizure disorder. While some individuals may experience a period of seizure freedom and be able to discontinue medication, this is not true for everyone. The duration of treatment varies, and some individuals may require long-term or even lifelong therapy.

A. Bethanechol (Urecholine)

Bethanechol is a cholinergic agonist used to treat urinary retention. It is not indicated for Alzheimer's disease.

B. Albuterol (Proventil)

Albuterol is a bronchodilator used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is not indicated for Alzheimer's disease.

C. Rivastigmine

Rivastigmine is a medication commonly used for the treatment of Alzheimer's disease. It belongs to a class of drugs called cholinesterase inhibitors, which work by increasing the levels of acetylcholine in the brain. This can help improve cognitive function in individuals with Alzheimer's disease.

D. Edrophonium (Enlon)

Edrophonium is a medication used for the diagnostic evaluation of Myasthenia Gravis. It is not used in the treatment of Alzheimer's disease.